3.74
price down icon0.53%   -0.02
after-market Dopo l'orario di chiusura: 3.73 -0.01 -0.27%
loading
Precedente Chiudi:
$3.76
Aprire:
$3.78
Volume 24 ore:
71,827
Relative Volume:
0.15
Capitalizzazione di mercato:
$38.11M
Reddito:
-
Utile/perdita netta:
$-23.87M
Rapporto P/E:
-0.1901
EPS:
-19.67
Flusso di cassa netto:
$-47.63M
1 W Prestazione:
-1.58%
1M Prestazione:
+4.47%
6M Prestazione:
+15.43%
1 anno Prestazione:
+7.16%
Intervallo 1D:
Value
$3.72
$3.8529
Intervallo di 1 settimana:
Value
$3.585
$3.91
Portata 52W:
Value
$2.30
$4.42

Polypid Ltd Stock (PYPD) Company Profile

Name
Nome
Polypid Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
61
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-13
Name
Ultimi documenti SEC
Name
PYPD's Discussions on Twitter

Confronta PYPD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PYPD
Polypid Ltd
3.74 38.32M 0 -23.87M -47.63M -19.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Polypid Ltd Stock (PYPD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-05 Iniziato Roth Capital Buy
2025-06-02 Ripresa H.C. Wainwright Buy
2025-01-28 Iniziato Rodman & Renshaw Buy
2021-09-14 Iniziato JMP Securities Mkt Outperform
2021-07-30 Iniziato Cantor Fitzgerald Overweight
2020-11-24 Aggiornamento Raymond James Outperform → Strong Buy
2020-08-10 Iniziato Alliance Global Partners Buy
2020-07-21 Iniziato BMO Capital Markets Outperform
2020-07-21 Iniziato Barclays Overweight
2020-07-21 Iniziato Raymond James Outperform
Mostra tutto

Polypid Ltd Borsa (PYPD) Ultime notizie

pulisher
Jul 24, 2025

Is PolyPid Ltd. a good long term investmentExceptional earning trajectories - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Will PolyPid Ltd. stock benefit from interest rate changesBreakout portfolio performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is PolyPid Ltd. stock a good hedge against inflationDynamic profit expansion - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

PolyPid Ltd. Stock Analysis and ForecastConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about PolyPid Ltd. stockUnmatched profit growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives PolyPid Ltd. stock priceConsistent high-yield stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 16, 2025

PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits - Yahoo Finance

Jul 16, 2025
pulisher
Jul 15, 2025

PolyPid's Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

How PolyPid Ltd. stock performs during market volatilityFree Exclusive Stock Market Insights - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PolyPid Ltd. stock price move sharplyFree Exclusive Stock Market Insights - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Analysts Set PolyPid Ltd. (NASDAQ:PYPD) Price Target at $11.80 - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Herald Publishes Coverage of PolyPid's Groundbreaking New 60-Day GLP-1 Delivery Tech - The Manila Times

Jul 15, 2025
pulisher
Jul 15, 2025

PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

Revolutionary 60-Day GLP-1 Injection Could Replace Weekly Diabetes Treatments, PolyPid Announces - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Why PolyPid Ltd. stock attracts strong analyst attentionReliable Low Risk Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

PolyPid (NASDAQ:PYPD) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 09, 2025

PolyPid (NASDAQ:PYPD) Stock Price Down 0.6% – Here’s What Happened - Defense World

Jul 09, 2025
pulisher
Jul 06, 2025

Is PolyPid Stock Undervalued? (NASDAQ: PYPD) - newsblaze.com

Jul 06, 2025
pulisher
Jul 03, 2025

PolyPid Announces $26.7 Million Warrant Inducement Transaction - Global Legal Chronicle

Jul 03, 2025
pulisher
Jun 25, 2025

PolyPid Approves Key Resolutions at Annual Shareholder Meeting - TipRanks

Jun 25, 2025
pulisher
Jun 20, 2025

Brokerages Set PolyPid Ltd. (NASDAQ:PYPD) PT at $11.25 - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

PolyPid (NASDAQ:PYPD) Given a $9.00 Price Target by Roth Capital Analysts - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Roth Capital Adjusts Price Target on PolyPid to $9 From $12, Maintains Buy Rating - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Roth Capital Adjusts PolyPid (PYPD) Price Target Amid New Financing | PYPD Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

PolyPid (NASDAQ:PYPD) Given New $14.00 Price Target at JMP Securities - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

PYPD: JMP Securities Lowers Price Target While Maintaining Marke - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

PolyPid (PYPD) Price Target Adjusted Amid Financing Developments - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

PolyPid stock price target lowered to $14 at JMP on warrant dilution By Investing.com - Investing.com South Africa

Jun 17, 2025

Polypid Ltd Azioni (PYPD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):